Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy
NCT01567826
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
87
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DRUG:
standard of care lipid therapy
DRUG:
Aggressive lipid therapy
Sponsor
Annapoorna Kini